Company / Total Debt
PUMA BIOTECHNOLOGY, INC. Total Debt History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$21.7M
FY2024
5-year range
$21.7M / $98.3M
FY2020-FY2024
Trend
-66.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt has fluctuated over the past 8 years, ranging from $22M in FY2024 to $152M in FY2018.
Based on SEC 10-K filings.
$22M in FY2024 with a 5-year CAGR of -25.6%.
Improved from $98M to $22M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -39.3%
- 5-Year CAGR
- -25.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -25.6%, indicating a declining trend.
- In FY2024, total debt decreased 66.9% year-over-year.
- Peak total debt was recorded in FY2018.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $21.7M | -66.9% |
| FY2023 | $65.7M | -33.2% |
| FY2022 | $98.3M | +1.3% |
| FY2021 | $97.1M | +15.6% |
| FY2020 | $84.0M | -11.5% |
| FY2019 | $95.0M | -37.5% |
| FY2018 | $151.9M | +213.3% |
| FY2017 | $48.5M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026